Showing results (1801-1810 of 2,488) with videos related to
Sort By:
Pageof 249
Nature Communications|May 3, 2023
Unveiling an indole alkaloid diketopiperazine biosynthetic pathway that features a unique stereoisomerase and multifunctional methyltransferaseGarrett Deletti, Sajan D Green, Caleb Weber, et al.Cancer|December 14, 2025
The effect of common medications on the efficacy of immune checkpoint inhibitorsDaria Brinzevich, Virginia Falvello, Sadiq S Rehmani, et al.Metabolites|July 27, 2022
The Influence of Orthopedic Surgery on Circulating Metabolite Levels, and their Associations with the Incidence of Postoperative DeliriumMijin Jung, Xiaobei Pan, Emma L Cunningham, et al.ACS Infectious Diseases|February 15, 2017
Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis InhibitorsAtefeh Garzan, Melisa J Willby, Huy X Ngo, et al.Genome Research|April 3, 2004
Aligning multiple genomic sequences with the threaded blockset alignerMathieu Blanchette, W James Kent, Cathy Riemer, et al.Plos One|March 28, 2008
An integrative genomic and epigenomic approach for the study of transcriptional regulationMaria E Figueroa, Mark Reimers, Reid F Thompson, et al.The New England Journal of Medicine|March 25, 1999
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolismC Kearon, M Gent, J Hirsh, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 1, 1995
Ossiculoplasty with polymaleinate ionomeric prosthesisJ T McElveen, J G Feghali, D M Barrs, et al.Nature Communications|June 20, 2018
Specific stereochemistry of OP-1074 disrupts estrogen receptor alpha helix 12 and confers pure antiestrogenic activityS W Fanning, L Hodges-Gallagher, D C Myles, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancerK Clarke, R L Basser, D Maher, et al.Pageof 249